NCT02445469 Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes Status TERMINATED Phase NA
NCT02422485 A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy Status COMPLETED Phase PHASE1
NCT02214862 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism Status COMPLETED Phase EARLY_PHASE1
NCT02167594 Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01824121 Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism Status UNKNOWN Phase PHASE1/PHASE2
NCT01815281 Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy. Status TERMINATED Phase NA
NCT01537549 Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy Status COMPLETED Phase PHASE1/PHASE2
NCT01348061 Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls Status COMPLETED Phase N/A
NCT01187888 Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy Status TERMINATED Phase PHASE3
NCT01174771 Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration Status COMPLETED Phase N/A
NCT01110720 Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy Status COMPLETED Phase PHASE2/PHASE3